Agios Pharmaceuticals
AGIO
AGIO
198 hedge funds and large institutions have $2.82B invested in Agios Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 65 increasing their positions, 73 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 73
25% less call options, than puts
Call options by funds: $24.2M | Put options by funds: $32.2M
33% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 43
Holders
198
Holding in Top 10
3
Calls
$24.2M
Puts
$32.2M
Top Buyers
| 1 | +$43.2M | |
| 2 | +$40.8M | |
| 3 | +$27.4M | |
| 4 |
CC
Casdin Capital
New York
|
+$27.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$24.1M |
Top Sellers
| 1 | -$139M | |
| 2 | -$15.4M | |
| 3 | -$13.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.9M |
| 5 |
Jennison Associates
New York
|
-$12.5M |